[1] | Wen H, Tuerganaili AJ, Shao YM, et al. Research achievements and challenges for echinococcosis control[J]. Chin J Parasitol Parasit Dis, 2015, 33(6): 466-471. (in Chinese) | | (温浩, (吐尔干艾力?阿吉, 邵英梅, 等. 棘球蚴病防治成就及面临的挑战[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 466-471.) | [2] | Casulli A, Siles-Lucas M, Tamarozzi F. Echinococcus granulosus sensu lato[J]. Trends Parasitol, 2019, 35(8): 663-664. | [3] | Wang LY, Qin M, Liu ZH, et al. Prevalence and spatial distribution characteristics of human echinococcosis in China[J]. PLoS Negl Trop Dis, 2021, 15(12): e0009996. | [4] | Zhang MY, Wu WP, Guan YY, et al. Analysis on disease burden of hydatid disease in China[J]. Chin J Parasitol Parasit Dis, 2018, 36(1): 15-19, 25. (in Chinese) | | (张梦媛, 伍卫平, 官亚宜, 等. 我国棘球蚴病疾病负担分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(1): 15-19, 25.) | [5] | Yuzhu ZM. Harm and control of sheep hydatid disease[J]. Chin J Tradit Vet Sci, 2022(8): 63-65. (in Chinese) | | (玉珠卓玛. 羊棘球蚴病的危害和防控[J]. 中兽医学杂志, 2022(8): 63-65.) | [6] | Acu?a SM, Floeter-Winter LM, Muxel SM. MicroRNAs: biological regulators inpathogen-host interactions[J]. Cells, 2020, 9(1): 113. | [7] | Yan C, Zhou QY, Wu J, et al. Csi-let-7a-5p delivered by extracellular vesicles from a liver fluke activates M1-like macrophages and exacerbates biliary injuries[J]. Proc Natl Acad Sci USA, 2021, 118(46): e2102206118. | [8] | Zhou X, Hou QL, Li B, et al. Effects of Echinococcus granulosus microcysts on the activation of peritoneal macrophages and the level of inflammatory factors in mice[J]. J Pathog Biol, 2021, 16(4): 411-418. (in Chinese) | | (周璇, 侯秋莲, 李斌, 等. 细粒棘球蚴微囊对小鼠腹腔巨噬细胞活化及炎症因子水平的影响[J]. 中国病原生物学杂志, 2021, 16(4): 411-418.) | [9] | Ren MD, Ning YY, Li M, et al. Differential expression of circulating microRNAs in patients with cystic echinococcosis and screening for specific diagnostic biomarkers for the disease[J]. Chin J Parasitol Parasit Dis, 2017, 35(5): 423-428. (in Chinese) | | (任梦迪, 宁玉烨, 黎明, 等. 细粒棘球蚴病患者外周血微小RNA的差异表达分析及其特异性诊断标志物的筛选[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(5): 423-428.) | [10] | Habibi B, Gholami S, Bagheri A, et al. Cystic echinococcosis microRNAs as potential noninvasive biomarkers: current insights and upcoming perspective[J]. Expert Rev Mol Diagn, 2023, 23(10): 885-894. | [11] | Mahami-Oskouei M, Norouzi B, Ahmadpour E, et al. Expression analysis of circulating miR-146a and miR-155 as novel biomarkers related to effective immune responses in human cystic echinococcosis[J]. Microb Pathog, 2021, 157: 104962. | [12] | Karami MF, Beiromvand M, Rafiei A, et al. Serum level of egr-miR-2a-3p as a potential diagnostic biomarker for cystic echinococcosis[J]. Acta Parasitol, 2023, 68(1): 114-121. | [13] | Cao DP, Jiang BF, Zhang YG, et al. MicroRNA-125b-5p is a promising novel plasma biomarker for alveolar echinococcosis in patients from the southern province of Qinghai[J]. BMC Infect Dis, 2021, 21(1): 246. | [14] | Mariconti M, Vola A, Manciulli T, et al. Role of microRNAs in host defense against Echinococcus granulosus infection: a preliminary assessment[J]. Immunol Res, 2019, 67(1): 93-97. | [15] | Orsten S, Baysal ?, Yabanoglu-Ciftci S, et al. MicroRNA expression profile in patients with cystic echinococcosis and identification of possible cellular pathways[J]. J Helminthol, 2021, 95: e1. | [16] | Xu JW, Li Y, Kang ML, et al. Multiple forms of cell death: a focus on the PI3K/AKT pathway[J]. J Cell Physiol, 2023, 238(9): 2026-2038. | [17] | Akbarzadeh M, Mihanfar A, Akbarzadeh S, et al. Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer[J]. Life Sci, 2021, 285: 119984. | [18] | Hu XP, Xie Q, Chen CF, et al. Let-7a inhibits T-cell proliferation and IFN-γ secretion by down-regulating STAT3 expression in patients with psoriasis[J]. Cell Physiol Biochem, 2017, 42(1): 115-125. | [19] | Wang JZ, Feng QL, Liang DK, et al. MiRNA-26a inhibits myocardial infarction-induced apoptosis by targeting PTEN via JAK/STAT pathways[J]. Cells Dev, 2021, 165: 203661. | [20] | Wang SL, Liu ZG, Wang JC, et al. miR-21 promotes osteoclastogenesis through activation of PI3K/Akt signaling by targeting Pten in RAW264.7 cells[J]. Mol Med Rep, 2020, 21(3): 1125-1132. |
|